80 related articles for article (PubMed ID: 26426782)
1. Bone morphogenetic protein receptor type II and inflammation are bringing old concepts into the new pulmonary arterial hypertension world.
Perros F; Bonnet S
Am J Respir Crit Care Med; 2015 Oct; 192(7):777-9. PubMed ID: 26426782
[No Abstract] [Full Text] [Related]
2. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
[TBL] [Abstract][Full Text] [Related]
3. Update in pulmonary arterial hypertension 2007.
Humbert M
Am J Respir Crit Care Med; 2008 Mar; 177(6):574-9. PubMed ID: 18316769
[No Abstract] [Full Text] [Related]
4. Severe pulmonary arterial hypertension: a forme fruste of cancer?
Humbert M; Hoeper MM
Am J Respir Crit Care Med; 2008 Sep; 178(6):551-2. PubMed ID: 18755928
[No Abstract] [Full Text] [Related]
5. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
[TBL] [Abstract][Full Text] [Related]
7. Heritable pulmonary arterial hypertension with elevated pulmonary wedge pressure.
Digne F; Sablayrolles JL; Montani D; Laperche T; Rousseau J; Guyon P; Stratiev V; Royer T; Attias D
Circulation; 2012 Aug; 126(9):e124-7. PubMed ID: 22927477
[No Abstract] [Full Text] [Related]
8. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
9. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
Kataoka M; Satoh T; Fukuda K
Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
[No Abstract] [Full Text] [Related]
10. Chloroquine in pulmonary arterial hypertension: a new role for an old drug?
Ryan JJ
Circ Cardiovasc Genet; 2013 Jun; 6(3):310-1. PubMed ID: 23778591
[No Abstract] [Full Text] [Related]
11. Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.
Wang G; Knight L; Ji R; Lawrence P; Kanaan U; Li L; Das A; Cui B; Zou W; Penny DJ; Fan Y
Int J Cardiol; 2014 Dec; 177(3):e167-9. PubMed ID: 25189502
[No Abstract] [Full Text] [Related]
12. Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
van der Bruggen CE; Happé CM; Goumans MJ; Bogaard HJ; Vonk Noordegraaf A; de Man FS
Circulation; 2016 Aug; 134(9):e117-8. PubMed ID: 27572883
[No Abstract] [Full Text] [Related]
13. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
Roberts KE; Barst RJ; McElroy JJ; Widlitz A; Chada K; Knowles JA; Morse JH
Chest; 2005 Dec; 128(6 Suppl):618S. PubMed ID: 16373874
[No Abstract] [Full Text] [Related]
14. Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.
West J; Tada Y; Fagan KA; Steudel W; Fouty BW; Harral JW; Miller M; Ozimek J; Tuder RM; Rodman DM
Chest; 2005 Dec; 128(6 Suppl):553S. PubMed ID: 16373822
[No Abstract] [Full Text] [Related]
15. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular pathobiology of pulmonary hypertension conference summary.
Rabinovitch M
Chest; 2005 Dec; 128(6 Suppl):642S-646S. PubMed ID: 16373886
[No Abstract] [Full Text] [Related]
17. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
Stewart DJ
Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
[No Abstract] [Full Text] [Related]
18. The mouse through the looking glass: a new door into the pathophysiology of pulmonary hypertension.
Rabinovitch M
Circ Res; 2004 Apr; 94(8):1001-4. PubMed ID: 15117827
[No Abstract] [Full Text] [Related]
19. Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension.
Rubin LJ
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893872
[No Abstract] [Full Text] [Related]
20. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
